Navigation Links
Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
Date:6/13/2008

DENVER, June 13 /PRNewswire-FirstCall/ -- Birner Dental Management Services, Inc. (Nasdaq: BDMS), operators of PERFECT TEETH dental practices announced its regular quarterly dividend. The Company's board of directors has declared a quarterly cash dividend of 17 cents per share of common stock. The dividend is payable July 11, 2008, to shareholders of record June 27, 2008.

Birner Dental Management Services, Inc. acquires, develops, and manages geographically dense dental practice networks in select markets in Colorado, New Mexico, and Arizona. Currently the Company manages 61 dental offices, of which 35 were acquired and 26 were de novo developments. The Company operates its dental offices under the PERFECT TEETH name.

Certain of the matters discussed herein may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from expectations. These include statements regarding the cash flow and financial position of the Company and the ability of the Company to pay dividends. These and other risks are set forth in the reports filed by the Company with the Securities and Exchange Commission.

For Further Information Contact:

Birner Dental Management Services, Inc.

Dennis Genty

Chief Financial Officer

(303) 691-0680


'/>"/>
SOURCE Birner Dental Management Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss First Quarter 2008 Results
2. Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006
3. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
4. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Year End and Fourth Quarter 2007 Results
5. Dental Services Expand to Serve More Than 280,000 Michigan Children
6. Essential dental treatment safe for pregnant women, says ADA journal study
7. ADA Comments on FDAs Settlement of Dental Amalgam Lawsuit
8. US FDA Admits Risks of Mercury Dental Fillings, Settles Lawsuit
9. Milestone Scientific Expands U.S. and Canadian Distribution Network With Addition of Patterson Dental Supply
10. Axsun Technologies Announces Strategic Supply Agreement for Integrated OCT Engines with Lantis Laser for Dental Imaging Applications
11. Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 2Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 3Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference 2Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Reminder Human Genome Sciences to Host Conference Call to Discuss Top Line Phase 3 Results for BENLYSTA 28TM 29 28Formerly LymphoStat B 28R 29 29 i 52058 1Reminder Human Genome Sciences to Host Conference Call to Discuss Top Line Phase 3 Results for BENLYSTA 28TM 29 28Formerly LymphoStat B 28R 29 29 i 52058 2BD PEPFAR Lab Strengthening Initiative Marks Progress in Fight Against HIV AIDS and TB in Sub Saharan Africa 52057 1BD PEPFAR Lab Strengthening Initiative Marks Progress in Fight Against HIV AIDS and TB in Sub Saharan Africa 52057 2BD PEPFAR Lab Strengthening Initiative Marks Progress in Fight Against HIV AIDS and TB in Sub Saharan Africa 52057 3BD PEPFAR Lab Strengthening Initiative Marks Progress in Fight Against HIV AIDS and TB in Sub Saharan Africa 52057 4Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 1Waging War on Wrinkles 3A Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport The Botox Alternative 52054 2